Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 21, 2022 16:01 ET | Source: Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals Announces the Appointment of Highly Accomplished Healthcare Executive Randall Kaye, M.D., as Chief Medical Officer

SAN DIEGO, March 21, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for...
March 03, 2022 16:05 ET | Source: Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals Provides Corporate Update and Reports Full Year 2021 Financial Results

Initiated the Phase 1b/2a PACIFIC Study, evaluating LP352 in participants with developmental and epileptic encephalopathies (DEEs)LP352 demonstrated statistically significant reduction of epileptiform...
January 05, 2022 08:30 ET | Source: Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference

SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for...
January 21, 2021 08:30 ET | Source: Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals Appoints Brandi L. Roberts as Chief Financial Officer

SAN DIEGO, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological...
January 20, 2021 16:30 ET | Source: Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals Appoints Phillip Schneider and Paul Sekhri to Board of Directors

SAN DIEGO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological...